| Registered number |
| Registered number: | |||||||
| Balance Sheet | |||||||
| as at |
|||||||
| Notes | 2024 | 2023 | |||||
| £ | £ | ||||||
| Fixed assets | |||||||
| Tangible assets | 4 | ||||||
| Current assets | |||||||
| Debtors | 5 | ||||||
| Cash at bank and in hand | |||||||
| Creditors: amounts falling due within one year | 6 | ( |
( |
||||
| Net current liabilities | ( |
( |
|||||
| Net liabilities | ( |
( |
|||||
| Capital and reserves | |||||||
| Called up share capital | |||||||
| Profit and loss account | ( |
( |
|||||
| Shareholders' funds | ( |
( |
|||||
| T M Pinto Maia Da Mota Baptista | |||||||
| Director | |||||||
| Approved by the board on |
|||||||
| Notes to the Accounts | ||||||||
| for the year ended |
||||||||
| 1 | Accounting policies | |||||||
| Basis of preparation of financial statements | ||||||||
| The following principal accounting policies have been applied: | ||||||||
| Going concern | ||||||||
| The directors have assessed the financial performance and future cash flow requirements of the Company at the date when the financial statements were authorised for issue. The Company has obtained the financial support letter from the parent company for at least 12 months from the date of the financial statements approval. The letter confirms that the parent company will provide where needed the necessary financial support so that the Company can meet its commitments and continue its business under normal conditions. The directors have satisfied themselves that the parent company is able to provide the financial support needed for at least 12 months from when the financial statements were authorised for issue to enable it to continue to trade. As a result, the directors believe the company has adequate resources to enable it to continue as a going concern. The financial statements have been prepared on a going concern basis, which the directors deem appropriate due to the financial support from the Parent Company. This support ensures that the Company can meet its commitments and continue its business operations under normal conditions. Due to the Company’s performance and financial position post year end, and availability of parental support, the directors do not consider there to be any material uncertainty relating to the Company’s ability to continue as a going concern and have prepared the financial statements on a going concern basis. |
||||||||
| Turnover | ||||||||
| Finance costs | ||||||||
the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instruments |
||||||||
| Tangible fixed assets | ||||||||
| Office equipment | 33% reducing balance | |||||||
| Computer equipment | 33% reducing balance | |||||||
| Financial instruments | ||||||||
| Debtors | ||||||||
| Creditors | ||||||||
| Taxation | ||||||||
| Provisions | ||||||||
| Foreign currency translation | ||||||||
| Functional and presentation currency | ||||||||
| Transactions and balances | ||||||||
| Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions. At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and nonmonetary items measured at fair value are measured using the exchange rate when fair value was determined. Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges. Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Income and Retained Earnings within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'. |
||||||||
| Pensions | ||||||||
The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the company in independently administered funds. |
||||||||
| 2 | Audit information | |||||||
| Senior statutory auditor: | ||||||||
| Firm: | ||||||||
| Date of audit report: | ||||||||
| 3 | Employees | 2024 | 2023 | |||||
| Number | Number | |||||||
| Average number of persons employed by the company | ||||||||
| 4 | Tangible fixed assets | |||||||
| Plant and machinery etc | ||||||||
| £ | ||||||||
| Cost | ||||||||
| At 1 January 2024 | ||||||||
| At 31 December 2024 | ||||||||
| Depreciation | ||||||||
| At 1 January 2024 | ||||||||
| Charge for the year | ||||||||
| At 31 December 2024 | ||||||||
| Net book value | ||||||||
| At 31 December 2024 | ||||||||
| At 31 December 2023 | ||||||||
| 5 | Debtors | 2024 | 2023 | |||||
| £ | £ | |||||||
| Trade debtors | ||||||||
| Other debtors | ||||||||
| 6 | Creditors: amounts falling due within one year | 2024 | 2023 | |||||
| £ | £ | |||||||
| Trade creditors | ||||||||
| Taxation and social security costs | ||||||||
| Other creditors | ||||||||
| 7 | Related party transactions | |||||||
| 8 | Controlling party | |||||||
The Company's ultimate controlling party is Feliciano Carvalho SGPS,S.A ., a company incorporated in Portugal. The results of the company are consolidated into the results of IN Agris SGPS SA which is an intermediate parent company. The consolidated financial statements of IN Agris SGPS SA are available at the registered office address of Zona Industrial do Cadaval Lt21, 2550-171 Cadaval, Portugal. |
||||||||
| 9 | Share capital | |||||||
| Share capital issued were 100 shares at £1.00 each and all of them were paid. | ||||||||
| 10 | Other information | |||||||
| XPLOR - BUSINESS SOLUTIONS LIMITED is a private company limited by shares and incorporated in England. Its registered office is: | ||||||||
| 1st Floor 10 Bloomsbury Way | ||||||||
| London | ||||||||
| England | ||||||||
| WC1A 2SL | ||||||||